A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus

NCT00657189 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Erythematosus, Systemic
Lupus

Interventions

DRUG: MEDI-545
DRUG: MEDI-545
DRUG: MEDI-545
DRUG: MEDI-545
DRUG: Placebo

Sponsor

MedImmune LLC